NASDAQ
ALX Oncology Holdings Inc. (ALXO) has a price/fcf ratio of -0.72x as of Monday, May 25, 2026. This represents a 87.22% increase compared to its 12-month average of -5.62x. The price-to-free-cash-flow ratio measures a stock's price relative to its free cash flow per share, reflecting how efficiently a company generates cash.
No price data available for this timeframe.